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Background: Paratuberculosis caused by Mycobacterium avium subsp. paratuberculosis (MAP) is difficult to control
due to a long phase of clinically non-apparent (latent) infection for which sensitive diagnostics are lacking. A
defined animal model for this phase of the infection can help to investigate host-MAP interactions in apparently
healthy animals and identify surrogate markers for disease progress and might also serve as challenge model for
vaccines. To establish such a model in goats, different age at inoculation and doses of oral inoculum of MAP were
compared. Clinical signs, faecal shedding as well as MAP-specific antibody, IFN-γ and IL-10 responses were used for
in vivo monitoring. At necropsy, about one year after inoculation (pi), pathomorphological findings and bacterial
organ burden (BOB) were scored.
Results: MAP infection manifested in 26/27 inoculated animals irrespective of age at inoculation and dose. Clinical
signs developed in three goats. Faecal shedding, IFN-γ and antibody responses emerged 6, 10–14 and 14 wpi,
respectively, and continued with large inter-individual variation. One year pi, lesions were detected in 26 and MAP
was cultured from tissues of 23 goats. Positive animals subdivided in those with high and low overall BOB. Intestinal
findings resembled paucibacillary lesions in 23 and multibacillary in 4 goats. Caseous and calcified granulomas
predominated in intestinal LNN. BOB and lesion score corresponded well in intestinal mucosa and oGALT but not
in intestinal LNN.
Conclusions: A defined experimental infection model for the clinically non-apparent phase of paratuberculosis was
established in goats as suitable basis for future studies.
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Paratuberculosis is a chronic granulomatous enteritis
caused by Mycobacterium avium subsp. paratuberculosis
(MAP) and affects domestic and wild ruminants world-
wide, causing considerable economic losses for the live-
stock industry [1,2]. Research to improve diagnostic
methods and prophylactic measures has been per-
formed for many years, but still many questions remain
unanswered. One reason is the extended clinically non-
apparent initial phase of the infection and the still
insufficient knowledge about the interactions between* Correspondence: heike.koehler@fli.bund.de
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unless otherwise stated.the host organism and the pathogen during this time
period.
Despite large numbers of naturally MAP infected ani-
mals, elucidation of host-pathogen interactions in the
early phase of the disease is only possible using the de-
fined conditions and variables of experimental animal
models. This is due to a diagnostic gap that allows
in vivo identification of infected animals only after sero-
conversion or after the onset of faecal shedding, which
become detectable late in the course of the disease with
large inter-individual variation [3]. Experimental animal
infection models allow the investigation of relevant
numbers of animals with defined infection status and
under identical conditions during the clinically non-
apparent phase of disease.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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verse domestic species, and furthermore, in small labora-
tory animals [4]. Study conditions were not standardized
among the experiments making comparisons difficult.
Generally, age at infection, dose and frequency of inocu-
lation, and duration of the experiment are decisive for
disease development [4,5]. International guidelines for
standardization of animal models for paratuberculosis
have been proposed only recently [5]. While cattle,
sheep and deer have been used extensively studies in
goats are rare and only small numbers of animals were
included [6-12]. Since marked individual variations of
host immune response and lesions were observed even
in the same experiment, the conclusions vary widely.
Performing experimental infections in goats has sev-
eral advantages in comparison to cattle and sheep. Goats
are susceptible to the three main groups of MAP, Type I,
II and III [13-15]. They are considered the least naturally
MAP resistant species due to a rather fast disease pro-
gress [16]. This allows a shorter duration of experiments.
In a study using Angora goats, specific IFN-γ responses
were observed already one month after challenge with
MAP positive gut mucosa and sero-conversion as early
as four months post infection (mpi). Clinical signs oc-
curred between 22 and 29 mpi [17]. In addition, the
feeding and housing requirements of goats are easier to
fulfil compared to cattle.
The aim of the present study was to establish a well
characterized experimental animal model for the clinic-
ally non-apparent phase of paratuberculosis in goats as a




Severe clinical signs of paratuberculosis were observed
in three of the MAP-inoculated animals (3/27). One ani-
mal each of group V2 and V4 developed non-treatable
diarrhea at 37 and 35 wpi, respectively, and had to be
necropsied, while the third goat of group V1 was cachec-
tic at 48 wpi. At 37, 38 and 39 wpi, 3 other goats of
group V2 died or had to be euthanized because of
neurologic signs. Post mortem examination revealed cer-
ebrocortical necrosis.
Shedding of MAP
MAP was detected repeatedly in the faeces of most of
the animals during the inoculation period (not shown).
Shedding stopped at 1 wpi in 13 of the 14 early inocu-
lated goats and in eight of the 13 late inoculated goats
and re-emerged about 6 wpi in all animals except one
goat of group V2. A large inter-individual variability of
shedding in terms of intensity (not shown) and time
course was observed independent from inoculation timeand dose. Essentially, three different shedding patterns
occurred: animals that stopped shedding before 34 wpi
(1), animals that shed MAP intermittently until necropsy
(2) and animals that shed MAP continuously during the
entire course of the experiment (3). Animals which had
to be necropsied before the end of the observation
period were not defined (Table 1).
Antibody response
The specific antibody response against MAP started at
14 wpi in the MAP-inoculated animals. The proportion
of antibody positive animals as well as antibody levels in-
creased until 22–26 wpi. S/P% varied largely between
individuals with no significant differences between
inoculation groups in general (Figure 1A). No serocon-
version was observed in three MAP-inoculated goats
from different groups (V1, V2 and V4) and in all control
animals.
IFN-γ response
A specific IFN-γ response of the MAP-inoculated ani-
mals against jPPD was first detected at 10–14 wpi. IFN-
γ release of the PBMC reached peak values at 22–26 wpi
and decreased afterwards. At 14 and 18 wpi, the IFN-γ
response of group V4 (late inoculated animals that re-
ceived 20 mg bwm per dose) exceeded that of the other
inoculated groups. Because of the large variation of the
response within the groups, statistically significant differ-
ences between inoculation groups occurred only inci-
dentally. In the control groups no jPPD-specific IFN-γ
release was induced (Figure 1B).
IL-10 response
A marked release of IL-10 was induced by in vitro
stimulation of PBMC from MAP-inoculated and con-
trol animals with jPPD at 6–14 wpi (K1, V1 and V2,
Figure 2A) or 6–10 wpi (K2, V3 and V4, Figure 2B).
Time course and magnitude of the response differed
between early and late inoculated groups including the
respective controls with peak responses at 14 wpi in
group K1, V1 and V2 and at 10 wpi in groups K2, V3
and V4. The control groups tended to have a lower IL-10
response than the two age matched MAP-inoculated
groups. This was more pronounced in the younger animals
(K1, V1 and V2). At later sampling dates the IL-10 response
of all groups decreased considerably (Figure 2A and B).
Bacterial organ burden (BOB)
MAP was culturally isolated after necropsy from at least
one tissue sample of 23 of the 27 MAP-inoculated goats.
The four MAP negative goats belonged to the groups V1
(n = 2), V2 (n = 1) and V4 (n = 1). These animals were al-
located to BOB category I. MAP positive animals could
be sub-divided into two categories (Table 2):
Table 1 Faecal shedding of MAP before and after oral inoculation and shedding category of animal
Group AnimalNo.
Week p. i. Shedding
categorya)-3 1 6 10 14 18 22 26 30 34 38 42 44 46
K1
1 - - - - - - - - - - - - - - -
2 - - co. - - - - - - - - # -
3 - n.a. - - - - - - - - - - - - -
4 - - co. - - - - - - - - - - - -
5 - - co. - - - - - - - - - - - -
6 - - - - - - - - - - - - - - -
V1
7 - - X X X X X X - - - - - - 1
8 - - X X X X X X X X X X X X 3
9 - - X X X X X X X X X X X X 3
10 - - X X X X X X X X X X X X 3
11 - - X X X X X X X - - - - - 1
12 - - X X X X X X X - - - - - 1
13 - - X X X - - - - - X X X X 2
V2
14 - - X X X X X X - X - # nd
15 - - X X - - X - - - - X - - 2
16 - - X X X X X X X - # nd
17 - X X X X X X - - - - # nd
18 - - X X X X X X - - - - - - 1
19 - - - X X X X X X X X X X X 3
20 - - X X - - - n.a. - - - # nd
K2
21 - - - - - - - - - - - - - - -
22 - - - - - - - - - - - - - - -
23 - - - - - - - - - - - - - - -
24 - - - - - - - - - - - - - - -
25 - - - - - - - - - - - - - - -
26 - - - - - - - - - - - - - - -
V3
27 - X X X X X - - X X X X X X 2
28 - - X X X X X X X - - - - - 1
29 - X X X X X X - - - - - - # nd
30 - - X X X X X - - - - - X - 2
31 - - X X X - - - - - - - - - 1
32 - X X X X - X - - - - - - - 1
V4
33 - - X X X X X X - - X - X - 2
34 - - X X - - - - - - - X - - 2
35 - X X X X X X X X X X X X X 3
36 - - X X X - - - - X # nd
37 - - X X X X X X X X X X X X 3
38 - - X X X X - - - - - - - - 1
39 - X X X - - - - - - - - - - 1
a)Shedding category: 1 – stopping before 34 wpi; 2 – intermittent; 3 – continuously; X, positive faecal culture; n.a., not available; co., contaminated; #, animal no
longer available (necropsy); nd, not defined.
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Figure 1 Time course and intensity of MAP-specific antibody response (A) and antigen-induced (Johnin, 4 μg/mL) IFN-γ response (B) of
inoculated and control goats. Box and Whisker Plot represents median value, 25% and 75% percentiles (box), range, outlier values (○), and
extreme values (*). Different letters indicate significant differences between groups (Mann–Whitney-U test, P≤ 0.05): a – V1 vs. V2, b – V1 vs. V3, c
– V1 vs. V4, d – V2 vs. V3, e – V2 vs. V4, f – V3 vs. V4.
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moderate amounts of MAP in intestinal tissues and
associated lymph nodes. The proportion of MAP
positive organs varied largely between these animals.
MAP could be recovered most often from the ICV-
LN, followed by the M-LN and ICVPP. The IPP and
the mucosa of the duodenum were positive only in a
few cases.BOB category III: Animals that had moderate to very
high amounts of MAP in most of the samples from in-
testinal tissues and associated lymph nodes. High
amounts of MAP were most frequently recovered from
the ICV-LN, the proximal and median jejunal LN and
the mucosa of the mid jejunum.
MAP was also isolated from extra-intestinal tissue of
nine animals, three from group V1, two each from groups
Figure 2 Time course and intensity of the antigen-induced (Johnin, 4 μg/mL) IL-10 response of early inoculated goats (A) and late
inoculated goats (B) and the corresponding control animals. Box and Whisker Plot: see Figure 1. Different letters indicate significant differences
between groups (Mann-Whitney-U test, P≤ 0.05): Figure 2A: a – K1 vs. V1, b – K1 vs. V2, c – V1 vs. V2; Figure 2B: a – K2 vs. V3, b – K2 vs. V4,
c – V3 vs. V4.
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tissue, the hepatic LN was most often positive (n = 8),
followed by the retropharyngeal LN (n = 5) and the tonsils
(n = 2). MAP was isolated from liver of five and spleen of
two animals (Table 3). Notably, most tissue samples of thecachectic goat were MAP positive, including superficial
cervical LN, kidney, diaphragm and gluteal muscle (not
shown).
On the individual animal level, no marked differences
in the BOB of intestinal lymph nodes, oGALT and
Table 2 Cultural detection of MAP in intestinal mucosa, oGALT and intestinal lymph nodes of the MAP-inoculated goats at necropsy
Group Animal
No.
Jejunal LNN Ileocol LNN JPP IPP ICVPP PCPP oGALT Duoden Jejunum Intestine Summary
BOB cat.prox. median distal LN BOB BOB cat. prox. distal BOB BOB cat. 1 2 3 BOB BOB cat.
V1 7 0a) 0 0 0 0 Ib) 0 0 0 0 0 0 I 0 0 0 0 0 I I
8c) 3.85 25.00 25.00 37.50 22.84 III 25.00 0 20.14 21.53 21.53 17.64 III 25.00 8.42 8.33 20.14 15.47 III III
9 22.63 50.00 40.00 40.00 38.16 III 40.00 35.00 40.00 62.50 co. 44.38 III co. 23.57 40.00 40.00 34.52 III III
10 15.00 32.50 25.00 40.00 28.13 III 38.75 33.33 26.25 co. co. 32.78 III 7.50 40.00 38.75 37.50 30.94 III III
11 0 4.96 6.75 6.25 4.49 II 0 0 0 3.13 0 0.63 II co. 0 16.52 0 5.51 II II
12 0 0 0 0 0 I 0 0 0 co. 0 0 I 0 0 0 0 0 I I
13 17.80 11.11 0 22.22 12.78 II 0 0 0 22.22 5.56 5.55 II 0 16.67 16.67 25.00 14.58 II II
V2 14d) 0 0 7.29 0 1.82 II 0 0 co. 8.33 0 2.08 II 0 0 co. co. 0 I II
15 16.67 8.33 8.33 8.33 10.42 II 16.67 0 4.17 0 8.33 5.83 II 0 8.33 0 0 2.08 II II
16e) 12.46 8.33 10.06 0 7.71 II 14.38 16.67 12.79 12.11 0 11.19 II 0 12.84 0 5.55 4.60 II II
17f) 0 0 0 7.50 1.88 II n.a. 0 0 0 1.85 0.46 II 0 0 0 0 0 I II
18 0 0 0 0 0 I 0 0 0 0 0 0 I 0 0 0 0 0 I I
19 6.25 20.83 25.00 31.89 20.97 III 20.83 11.11 26.39 16.67 co. 18.75 III 0 16.67 20.83 20.83 14.58 II III
20g) 0 0 0 0 0 I 0 0 0 0 0 0 I 0 16.67 0 0 0.42 II II
V3 27 17.14 12.33 15.48 36.61 20.39 III 4.17 9.72 15.47 16.67 8.33 10.87 II 0 15.08 32.14 20.24 16.87 III III
28 13.26 14.44 4.17 9.33 10.30 II 8.33 2.17 0 9.33 co. 4.96 II 5.00 8.33 11.11 10.00 8.61 II II
29 0 4.80 5.88 0 2.67 II co. 0 0 5.00 co. 1.67 II 0 0 0 0 0 I II
30 0 3.75 0 8.69 3.11 II 16.67 0 2.50 10.00 33.33 12.50 II 0 10.00 0 0 2.50 II II
31 0 0 0 8.63 2.16 II co. 0 0 0 0 0 I co. 0 0 0 0 I II
32 0 0 0 2.00 0.5 II 0 0 0 0 co. 0 I 0 0 0 0 0 I II
V4 33 10.24 12.54 9.42 20.51 13.18 II 4.76 0 0 0 18.89 4.73 II 0 8.33 25.00 0 8.33 II II
34 9.40 16.91 0 11.11 9.35 II co. 0 0 0 0 0 I 0 0 19.09 8.33 6.86 II II
35 33.33 33.33 1.85 41.67 27.55 III 37.37 0 25.00 16.67 20.21 19.85 III 4.17 16.67 25.00 16.67 15.62 III III
36h) 8.89 13.29 16.67 0 9.71 II 0 10.00 8.33 14.34 13.33 9.20 II 3.33 0 co. 0 1.11 II II
37 35.00 30.00 35.00 40.00 35.00 III 33.33 23.81 8.33 co. 4.76 17.56 III 0 33.33 35.71 10.00 19.76 III III
38 6.67 0 18.75 15.86 10.31 II co. co. co. 0 0 0 I 0 co. co. 0 0 I II
39 0 0 0 0 0 I 0 0 0 0 0 0 I 0 0 0 0 0 I I
a)Growth Index b)BOB category: I, no growth; II, BOB ≤ 15; III, BOB > 15; c)cachectic; d)died 39 wpi; e)necropsied 37 wpi, diarrhea; f)died 37 wpi; g)necropsied 38 wpi; h)necropsied 35 wpi, diarrhea; prox. proximal; Ileocol












Table 3 Cultural isolation of MAP and lesions in extra-intestinal sites
Group Animal
No.
Liver Hepatic LN Spleen Retropharyngeal LN Tonsil
Culture gInf MAP-IHC Culture gInf MAP-IHC Culture gInf MAP-IHC Culture gInf MAP-IHC Culture gInf MAP-IHC
V1 7 0a) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
8 33.33 +++b) 0 25.00 ++ 0 12.50 0 0 10.42 0 0 26.04 ++ 0
9 0 0 0 13.93 0 0 0 0 0 0 0 0 0 0 0
10 21.78 ++ 0 14.16 0 0 11.46 0 0 0 0 0 0 0 0
11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
12 0 + 0 0 0 0 0 0 0 0 0 0 0 0 0
13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
V2 14c) co. 0 0 0 ++ 0 0 0 0 0 0 0 0 0 0
15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
16c) 0 0 0 1.9 + 0 0 0 0 0 0 0 0 0 0
17c) 0 0 0 0 ++ 0 0 0 0 5.26 0 0 0 0 0
18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
19 0 +++ 0 6.6 ++ 0 0 0 0 4.16 + 0 3.57 0 0
20c) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
V3 27 12.50 0 0 8.33 0 0 0 0 0 0 0 0 0 0 0
28 co. 0 0 0 0 0 0 0 0 0 0 0 0 0 0
29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
30 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
31 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
V4 33 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
35 16.78 0 0 8.33 0 0 0 0 0 8.33 0 0 0 0 0
36d) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
37 4.29 0 0 22.50 0 0 0 0 0 7.94 0 0 0 0 0
38 co. 0 0 0 0 0 0 0 0 0 0 0 0 0 0
39 co. 0 0 0 0 0 0 0 0 0 0 0 0 0 0
a)Growth Index b)granulomatous infiltrate: 0, none; +, mild, focal; ++, moderate, multifocal; +++, severe, diffuse; c)necropsy at 37–39 wpi; d)necropsy at 35 wpi; co. contaminated; na. not available; gInf, granulomatous
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BOB category III, while variability was higher in category
II animals. Culturally negative and the two categories of
culturally positive animals were distributed over all in-
oculation groups.
Gross pathology
Macroscopic lesions were most frequently (21 out of 27
goats) seen in mesenteric and ileocolic lymph nodes and
oGALT, especially JPPs. Affected lymph nodes were en-
larged and had areas of necrosis and calcification varying
from 1 mm to extensive throughout the entire lymph
node (Figure 3A). JPPs had reduced thickness and were
indented in most of the goats (Figure 4A), in a few goats
they were thickened and firm (Table 4). The surface was
occasionally ulcerated. Chronic villous serositis was
regularly seen at the serosal aspect of altered JPPs
(Figure 4B). Lesions were inconsistently seen in the IPP,
ICVPP and PCPP. Both intestinal lymph nodes as well
as oGALT were altered in most goats. Intestinal wall
outside oGALT was affected less frequently (12 out of
27 goats, Table 4). Multiple small (0.5–2 cm) foci of
thickened intestinal mucosa were seen in the small intes-
tine of seven, thickening of segments in three and of the
entire length in another three goats. The latter was asso-
ciated with corrugated intestinal mucosa. Thickened and
nodular lymphatics were frequent in the altered seg-
ments of intestine. Intestinal lesions were restricted to
the small intestine and were seen only in goats which
had also lesions in JPPs and intestinal lymph nodes. All
goats from the control groups and one goat of groups
V3 and V4 each were without paratuberculous lesions. A
few helminths were seen in a few goats of all groups.
Histopathology and immunohistochemistry for MAP
Histopathology confirmed the macroscopic lesions in in-
testinal lymph nodes (Table 4). Granulomas with extensiveFigure 3 Lesions in mesenteric lymph nodes. Enlarged lymph node wit
with extensive necrosis and calcification (B, goat 38, HE, bar = 500 μm). Sm
degenerated cell were seen in granulomas of most goats (C, goat 11, immun
granulomas in 4 goats (D, goat 19, immunohistochemistry MAP, bar = 10 μm)central necrosis and calcification surrounded by a variable
amount of granulomatous infiltrate, fibrocytes and lym-
phocytes predominated (Figure 3B). Small amounts of
mycobacterial material (paucibacillary) were regularly seen
by IHC in the necrotic centers (Figure 3C). Multibacillary
lesions were seen in four of the early inoculated goats
(Figure 3D). Multifocal granulomatous infiltrates of
epitheloid cells and multinucleated giant cells (MGCs)
were seen in subcapsular sinuses, along trabeculae and
adjacent to granulomas in 18 goats additionally to
granulomas and in 2 goats as only lesions. Single myco-
bacteria were detected occasionally in these infiltrates.
To allow better comparison with immunologic and
bacterial culture data, lesions in intestinal lymph nodes
were scored as no lesions (category I), mild lesions (cat-
egory II) or severe lesions (category III). Animals with
category III lesions predominated. Goats with mild le-
sions were particularly frequent in V3. One goat of V2
and three of V4 had no lesions in intestinal lymph nodes
(category I).
Macroscopic lesions in JPPs were confirmed in all af-
fected goats by histology. In the majority of goats (16
out of 20), the architecture of the organized lymphoid
tissue was markedly altered with few and small lymphoid
follicles and severe and sometimes complete loss of
interfollicular lymphoid tissue (Figure 5A). Lesions were
characterized by small focal to multifocal groups of
epitheloid cells and few MGCs and extensive infiltra-
tion with lymphocytes and plasma cells (lesion type C,
Figure 5B). The mucosal surface was irregular with occa-
sional ulcers. A mild to severe chronic fibro-proliferative
serositis was seen regularly. Lesions were paucibacillary in
one goat, multibacillary in one goat and without mycobac-
teria by IHC in 14 goats (Figure 5C). In three goats, small
granulomatous infiltrates without changes of the tissue
architecture were seen in addition (lesion type A). Two
goats from the early inoculated groups had more extensiveh focal necrosis and calcification (A, goat 9, bar = 1 cm), granuloma
all foci of granular staining for mycobacteria possibly associated with a
ohistochemistry MAP, bar = 10 μm), numerous mycobacteria throughout
.
Figure 4 Lesions at Peyer´s patches. Indented Peyer’s patch in jejunum. (A, goat 13). Circumscribed villous serositis (arrow) is frequent in
altered Peyer’s patches (B, goat 31). Bar = 1 cm.
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phocytes predominantly in the interfollicular areas (lesion
type B). Mycobacteria were not detected in type A and B
lesions by IHC. Multifocal, moderate to severe infil-
trates of predominantly epitheloid cells (lesion type D)
occurred in one goat of group V1 and one goat of group
V4 (Figure 6A, B). Numerous mycobacteria were present
in the epitheloid cells of these lesions (Figure 6C).
Comparable lesions were detected in other sites with
oGALT, e.g. IPP, ICVPP, PCPP and in the rectum, but
less frequently.
Lesions in the intestine outside oGALT were charac-
terized by multifocal infiltrates of epitheloid cells and
few MGCs. MGCs predominated in small and focal le-
sions which were often missed by the macroscopic
examination. Mycobacteria were detected in 3 of the 15
goats with intestinal lesions.
Lesions in oGALTand small intestine were also classified
as lesions category I to III. Besides the extent of lesions
and number of mycobacteria detected by IHC, the number
of oGALT (n = 7) and intestinal sites (n = 5) collected for
histology with lesions was included. A mix of goats with all
lesions categories were seen in all groups. Goats with le-
sions category II in oGALT and without lesions (category
I) in small intestine were more frequent in group V2.
Association between lesion category and BOB category
A clear association between lesion and BOB category
was noted in oGALT and small intestinal tissue (Table 5,
A and B). No to mild lesions predominated in those tis-
sues where no bacterial growth had been detected. Tis-
sues with bacterial organ burden were characterized by
mild to severe lesions, the strongest association between
severe lesions and high BOB was noted in the oGALT.
In contrast, no association between lesion and BOB cat-
egory could be established in the intestinal lymph nodes.
Severe lesions predominated in LNN with low and even
without BOB (Table 5, C).
Discussion
A well characterized experimental model for the clinically
non-apparent phase of paratuberculosis was establishedwhich fulfils the following requirements for the experi-
mental design [18]: (1) defined host, (2) standardized
infection, (3) standardized stage of disease, (4) appropriate
controls.
Goats of the breed Thüringer Wald Ziege were se-
lected as host species. This is an independent native
German breed of dairy goats which has been maintained
without cross-breeding since 1935 [19]. All kids came
from one pedigree herd with no history of clinical para-
tuberculosis. Freedom from disease had been verified by
the negative outcome of faecal culture of all adult goats
prior to purchase of the kids and was confirmed by lack
of lesions as well as negative results of faecal and tissue
culture of all control animals.
For standardization of the infection special attention
was paid to the strain selection and preparation of the
inoculum. The isolate used for inoculation (JII-1961) is a
Type II (C-) strain of MAP genetically highly similar to
K10 (P. Möbius, personal communication). It was iso-
lated from the ICV-LN of a dairy cow with paratubercu-
losis [20]. The inoculum was prepared from a bacterial
stock which had been established after a few passages of
the isolate. Aliquots of this stock are available for further
experiments. The MAP dose was standardized as recom-
mended [5] by adjusting the bacterial wet mass used for
preparation of the inoculum.
Four different inoculation regimens were compared in
order to optimize the model to be representative for the
clinically non-apparent phase of the disease. Three ani-
mals of the group inoculated with the high dose at early
age developed neurological signs which could not be
attributed to MAP infection. An association between
cerebrocortical necrosis and paratuberculosis has not
been reported in the literature.
In addition to clinical signs, the course of the disease
was monitored in vivo by four parameters (faecal shed-
ding, specific serum antibodies against MAP, antigen-
induced IFN-γ and IL-10 response), which have also
been used by other investigators (reviewed by [5]), thus
allowing comparison between studies. The blood param-
eters in particular were seen as surrogates of host-
pathogen interactions in clinically healthy animals.























V1 7 ✓, e G 2 III - - 0 0 I - - 0 0 I III
8 ✓, e G, gInf 2 III ✓ mf , D 2 7 III ✓, E mf +++ 2 4 III III
9 ✓, e G, gInf 1 II ✓ mf , C 2 5 III ✓, S mf ++ 0 4 III III
10 ✓, f G, gInf 1 III ✓ mf, C 1 4 III ✓, S mf + 2 4 III III
11 ✓, e G, gInf 1 III ✓ f/mf, C/A 0 2 II - f + 0 1 II II
12 ✓, e G 1 III - - 0 0 I - - 0 0 I III
13 - gInf 1 II ✓ f/mf, B 0 1 II ✓, MF mf + 0 2 II II
V2 14a ✓, e G, gInf 1 III ✓ f, C 0 3 II - - 0 0 I II
15 - - 0 I ✓ mf, C 0 1 II ✓, MF - 0 0 I II
16a ✓, e G, gInf 1 III ✓ mf, B 0 3 II ✓, E mf ++ 0 4 III III
17a ✓, e G, gInf 1 III ✓ mf, C 0 1 II - - 0 0 I II
18 ✓, e G, gInf 2 III ✓ mf, C 0 3 II - - 0 0 I II
19 ✓, e G, gInf 2 III ✓ mf/d, C 0 6 III ✓, S mf ++ 0 4 III III
20a ✓, f G, gInf 1 II - - 0 0 I - - 0 0 I II
V3 27 ✓, f G 0 II ✓ mf, C/A 0 5 III ✓, S, MF f + 0 1 II II
28 ✓, e G, gInf 1 II ✓ mf, C 0 1 II ✓, MF f ++ 0 3 III II
29 ✓, f G, gInf 1 II ✓ f, C 0 2 II - - 0 0 I II
30 ✓, f G, gInf 1 II ✓ mf, C 0 4 III - - 0 0 I II
31 - gInf 0 II - - 0 0 I - - 0 0 I II
32 ✓, e G, gInf 1 III ✓ f, C 0 2 II - f ++ 0 1 II II
V4 33 ✓, e G, gInf 1 III ✓ f/mf, C/A 0 2 II ✓, MF mf + 0 1 II II
34 - - 0 I ✓ mf, C 0 1 II - f + 0 2 II II
35 ✓, e G, gInf 1 III ✓ mf, C 0 7 III ✓, MF mf ++ 0 4 III III
36b - - 0 I ✓ mf, C 0 4 III - f + 0 1 II II
37 ✓, e G, gInf 1 III ✓ mf, D 2 4 III ✓, MF mf +/++ 1 4 III III
38 ✓, e G, gInf 1 III - - 0 0 I - - 0 0 I III
39 - - 0 I - - 0 0 I - - 0 0 I I
✓ paratuberculous lesion; − no paratuberculous lesion; LNN lymph nodes; G granuloma; gInf granulomatous infiltrate; MAP IHC MAP detected by IHC; nd not done; anecropsy at 37–39 wpi; bnecropsy at 35 wpi; 0 no
MAP; 1 paucibacillary; 2 multibacillary; f focal; mf multifocal; e extensive; A-D type of histological lesion (see text); +, ++, +++ mild, moderate, severe granulomatous infiltrates; E entire small intestine with thickened
intestinal wall and corrugated mucosa; S segments of small intestine with thickened intestinal wall and corrugated mucosa; MF 0.5 – 2 cm thickening of the intestinal mucosa with central depression; lesion categories:












Figure 5 Severely atrophic Peyer’s patch in jejunum lacking lymphoid follicles and interfollicular areas, but with marked villous serositis.
(A, goat 28). The organized lymphoid tissue is replaced by multiple small foci of epitheloid cells and MGCs and an extensive infiltrate of lymphocytes
and plasma cells (A, B higher magnification of A, HE). There are no mycobacteria in the granulomatous infiltrate (C, immunohistochemistry MAP). Bar
in A = 500 μm, bar in B = 100 μm, bar in C = 10 μm.
Köhler et al. BMC Veterinary Research  (2015) 11:74 Page 11 of 19The experiment was terminated about one year after
inoculation independent of the appearance of clinical
signs. At that time, the proportion of animals that devel-
oped clinical signs characteristic of paratuberculosis was
rather low and independent from group allocation. Tis-
sue lesions and level of tissue colonization with MAP
were quantified as measure for the manifestation and
dissemination of the infection. The results confirmed
that the majority of the inoculated goats were in the
clinically non-apparent phase of paratuberculosis. The
results of the in vivo parameters indicate that even the
animal without signs of infection at necropsy (goat no.
39) had undergone transient infection.
Appropriate numbers of age-matched control animals
of the same origin were included in the study and exam-
ined in the same manner as the inoculated goats. The
animals were kept in a separate room of the same ani-
mal facility as the inoculated groups to assure similar
environmental, feeding and housing conditions. They
were neither exposed to nor infected by MAP as proven
by the results of the examinations conducted in vivo andFigure 6 Jejunum Peyer’s patch with severe granulomatous infiltrate.
the granulomatous infiltrate (C, immunohistochemistry MAP). Bar in A = 50after necropsy. This confirms that the applied sanitary
and management measures were sufficient to prevent
unwanted carry-over of MAP.
Onset and time course of faecal shedding, antibody re-
sponse, and antigen-specific IFN-γ response was similar to
one [10] and completely different from another study in
goats [6], further supporting the need for standardization
of the model. In both studies the total inoculation doses
were considerably higher than in the present one, and the
goats were challenged with a MAP strain of caprine origin
whereas our goats received an isolate of bovine origin. Dif-
ferences in virulence or host adaptation of the MAP
strains used for inoculation have to be taken into account.
However, direct comparison of the virulence of bovine
and caprine MAP isolates for goats has not been per-
formed yet. Higher responsiveness and/or a quicker onset
of the host response to C-strains of MAP in comparison
to S-strains has been demonstrated in sheep, goats, cattle
[16,17,21] and deer [22]. Another explanation might be a
different susceptibility of different goat breeds to MAP
although scientific evidence is lacking [23].(goat 37, A, B higher magnification of A, HE). Many mycobacteria in
0 μm, bar in B = 100 μm, bar in C = 10 μm.
Table 5 Relation between histological score and bacterial organ burden of selected organs
Bacterial organ burden category (n) p χ2-test (Pearson)
A) Intestinal mucosa I II III Total
Lesion category (n) I 9 3 0 12 0.002
II 1 5 1 7
III 0 4 4 8
Total 10 12 5 27
B) oGALT I II III Total
I 6 0 0 6 ≤ 0.001
II 3 9 0 12
III 0 3 6 9
Total 9 12 6 27
C) Intestinal LNN I II III Total
I 1 3 0 4 0.703
II 1 5 2 8
III 3 7 5 15
Total 5 15 7 27
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body response started almost at the same time. This
matches with findings in naturally infected goats where
the onset of the IFN-γ response usually preceded the
humoral response, but positive antibody titers could
sometimes be seen simultaneously with, or even prior to
the IFN-γ response [24]. The paradigm of a Th1 over
Th2 dominancy in the early stages of MAP infection,
that has been postulated for many years, is challenged
by these data, which are further confirmed by the results
of experimental MAP infections of sheep [25]. Consider-
able variation of the individual host responses was seen
in the further course of the experiment which is in
agreement with findings in naturally infected goats
[24,26] as well as experimentally infected sheep [21,25]
and cattle [16].
Transient elevation of antigen-induced IL-10 release
by PBMC was observed in MAP-inoculated and control
goats up to 14 wpi depending on the age at inoculation,
with significantly higher levels in MAP-inoculated ani-
mals compared to age–matched controls (K1) in the
early inoculated groups (V1, V2). Similar findings were
reported from calves after experimental oral inoculation
of mucosal scrapings from a cow with clinical paratuber-
culosis [27]. It can be speculated that a transient anti-
inflammatory response is induced in very young goats
shortly after MAP infection which is subsequently
down-regulated by a strong IFN-γ response indicative of
pro-inflammatory mechanisms. In a leprosy model, IFN-
γ differentially modulated IL-12 and IL-10 production
resulting in up-regulation of IL-12 and down-regulation
of IL-10 release in response to Mycobacterium leprae
stimulation [28].Morphological investigation and cultivation of MAP
from tissues collected at necropsy one year after inocu-
lation were used to confirm the infection. Lesions and/
or MAP were detected in 26 of the 27 goats inoculated
indicating a very high infection rate. This has been
reported in several other studies in goats and confirms
the good reproducibility of MAP-infection using this
model [10,17,29,30]. Lesions induced by the experi-
mental infection were comparable to those in natural
infection [31,32]. There were minor differences: (1)
Naturally infected goats had a higher frequency of dif-
fuse lesions in the small intestine indicating a more
advanced stage of infection in the goats sampled at
slaughter [31,32]. (2) JPP and ICVPP were most con-
sistently affected in the present and other experimental
studies [30,33], whereas lesions predominated in IPP,
terminal ileum and ICVPP in naturally infected goats
and also some experimental studies [29,31,32,34].
Lesions were seen in intestinal lymph nodes in similar
frequency as in oGALT, whereas other studies report a
predominance of lesions in intestinal lymph nodes
[29]. These differences might be related to the sam-
pling procedures. (4) The number of intestinal lymph
nodes with caseous and calcified granulomas was
markedly higher compared to naturally infected goats
[31]. It remains unresolved whether virulence of the
MAP strain, stage of infection or susceptibility of the
breed have contributed to this. Caseous and calcified
granulomas are characteristic of MAP infection in
goats and not common in other ruminant species.
They may allow comparative studies for other myco-
bacterial infections even beyond the scope of
paratuberculosis.
Köhler et al. BMC Veterinary Research  (2015) 11:74 Page 13 of 19Isolation of MAP from tissues was not possible in four
of the inoculated goats, confirming findings in other ex-
perimental studies [6,7,9]. Obviously, the organism was
cleared to a large extent or changed to a viable-but-non-
culturable state after manifestation of infection, since all
four goats shed MAP until at least 10 wpi, all mounted a
specific IFN-γ response, and tissue lesions were found in
three of them. Culture results were assessed semi-
quantitatively, an approach utilized only in a few other
published studies in goats and sheep [10,29,35]. This
allowed allocation of the animals to BOB categories as a
prerequisite for additional comparative analyses. In
agreement with another experimental study [6] viable
MAP was most often recovered from lymph nodes and
to a lesser extent from intestinal mucosa and oGALT. In
contrast, no difference in the proportion of positive
lymph nodes and intestinal samples was obvious in nat-
urally infected adult goats [26]. This seems to be due to
the more advanced stage of the disease in these animals
in comparison to the experimental studies. Viable MAP
was also recovered from extra-intestinal sites, pointing
to dissemination of the organisms already in the clinic-
ally non-apparent phase of the disease and confirming
findings in experimentally [10] and naturally infected
goats [26].
Two different doses of MAP and two different age pe-
riods for inoculation were compared in order to identify
the optimal infection regimen. There was considerable
inter-individual variation in faecal shedding, the in vivo-
host responses, BOB and lesions at necropsy, but no sig-
nificant differences between the treatment groups except
for an earlier onset of the IFN-γ response and a reduced
IL-10 response in the animals that received high MAP
doses starting at 42 days after birth (group V4). This is
not unexpected, since the modifications of the inocula-
tion dose and the age at inoculation were only minimal
in the present experiment in comparison to other stud-
ies performed in sheep and deer [22,35-37].
The readout parameters, lesion scores and BOB, used
at the end of the experiment were closely matching in
the intestinal tract, but markedly different in the intes-
tinal LN. Differences between lesion scores and BOB
were more frequent in goats with milder lesions where
oGALT and intestinal mucosa were not uniformly af-
fected. In the intestinal LN, histological classification did
not allow conclusions about BOB. In particular, low
BOB was associated with no, mild and severe lesions.
These differences are not unexpected, since the lesions
reflect tissue damage caused by MAP and the reaction
of the host to MAP, and cultural results the ability of
MAP to survive, replicate and spread. It can be specu-
lated that MAP is more efficiently cleared from intes-
tinal LN than from mucosa or oGALT because of
tissue-specific control mechanisms. The granulomasthat predominated in the intestinal LN may either allow
the host to control the mycobacterial infection or MAP
to persist [38].
Overall lesion and BOB categories showed agreement
in the majority of goats. Only in three goats, MAP was
not cultivated, but caseous and calcifying granulomas
were present in intestinal lymph nodes and in three
goats, lesions were considered severe, but BOB was low.
Two factors might have contributed to these discrepan-
cies: (1) the massive host immune response – seen as se-
vere lesions - may have reduced the amount of viable
MAP in the tissue and (2) organization and removal of
lesions after the clearance of the pathogen take an ex-
tended period of time. Lesions and BOB categories will
allow subgrouping of animals for retrospective analyses
of in vivo data.Conclusions
A well characterized experimental animal model of para-
tuberculosis was established in goats. The lack of clinical
signs and the finding of paucibacillary lesions in the ma-
jority of goats indicate that this experimental model
targets as intended the clinically non-apparent phase of
infection. Monitoring of host-pathogen interaction
in vivo and post mortem findings confirmed inter-
individual differences in the progress of disease and will
allow subgrouping for comparative investigations. This
animal model provides the basis for future studies of
pathogenesis and early diagnosis of MAP infection.Methods
Legislation and ethical approval
This study was carried out in strict accordance with
European and National Law for the Care and Use of An-
imals. The protocol was approved by the Committee on
the Ethics of Animal Experiments and the Protection of
Animals of the State of Thuringia, Germany (Permit
Number: 04-002/08). All experiments were done in con-
tainment of biosafety level 2 under supervision of the
authorized institutional Agent for Animal Protection.
During the entire study, every effort was made to
minimize suffering.Animals
Thirty nine male goats kids (breed: ‘Thüringer Wald
Ziege’) were included. Animals originated from a con-
ventionally raised herd of dairy goats with no history
of clinical paratuberculosis. Before purchase, all adult
goats of the herd were tested once for the presence of
MAP by faecal culture and were proved to be negative.
Clinically healthy goat kids aged 3 to 5 days and
weighing between 2.6 and 6.0 kg (4.01 ± 0.76 kg; mean
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Friedrich-Loeffler-Institut in Jena.
The goats were allocated to six different groups (n = 6-
7) considering weight at birth, age, sire and dam in order
to prevent full siblings in the same group, get an equal
distribution of the offspring of one sire over the groups
and adjust the mean body weight and the mean age of
the groups. Throughout the entire study, animals of the
different groups were kept in separate rooms but under
equal housing and feeding conditions, and in accordance
with international guidelines for animal welfare [39,40].
Feeding was adjusted to the age-dependent nutritional
needs of the animals. The kids received goat milk from the
herd of origin up to day 8 after birth, then commercial
milk replacer for goat kids (Denkamilk capritop, Denkavit,
Warendorf, Germany) up to the age of 10 weeks. Water,
mineral blocks without copper, containing 37 % sodium,
1.1 % calcium, 0.6 % magnesium and trace elements
(Mineralleckstein ohne Kupfer, esco – european salt
company, Hannover, Germany) and hay were supplied
ad libitum during the whole course of the experiment.
Small amounts of pelleted concentrates were offered
already during milk feeding. After weaning protein rich
pelleted concentrates for goats (Alleinfuttermittel für
Ziegenmastlämmer and Milchleistungsfutter II, both
LHG Landhandelsgesellschaft, Schmölln, Germany)
containing vitamin A, D3 and E were fed. The ration of
concentrates was gradually increased up to 500 grams
per day. None of the given feed contained antibiotics.
The animals were castrated at the age of 12 weeks.
During the whole course of the experiment the animals
were neither treated with systemic antibiotics nor im-
munosuppressive drugs.
Study design
Four of the six groups were challenged with MAP (V1 –
V4; n = 6-7), two groups served as controls (K1, K2; n =
6, Table 6). With respect to the suggested guidelines
[5,23], four different inoculation regimens were com-
pared. Treatment of the groups differed as follows: Oral
inoculation with MAP started 3–5 days post natumTable 6 Study design: group allocation, time point and dose
Start of inoculation period 3-5 dpn
Group K1 V1
Number of animals (n) 6 7
Inoculation dose per day (mg bwm) - 10
Average bacterial counts/mL - 2.08 ±
Average bacterial counts/inoculum - 2.08x108
Total inoculation dose - 2.08x109
Time of necropsy (wpi) 48a) 48
dpn, days post natum; bwm, bacterial wet mass; wpi, weeks post infection; a)one an
animal each was necropsied at 37 and 38 wpi; c)one animal was necropsied at 35 w(dpn) for two early inoculated groups (V1, V2) and at 42
dpn for two late inoculated groups (V3, V4). Inoculation
was performed ten times every two to three days. One
group each of the early and the late inoculated goats re-
ceived 10 mg bacterial wet mass (bwm, V1, V3) per dose,
the others received 20 mg bwm of MAP per dose (V2,
V4). The age matched controls were sham-inoculated at
the same time (K1 starting at 3–5 dpn, K2 starting at 42
dpn, Table 6).
Each goat underwent daily clinical examination from
the beginning of the experiment until necropsy. Parame-
ters to follow the course of infection were faecal shed-
ding of MAP, antibody response in serum and specific
IFN-γ and IL-10 responses of peripheral blood mono-
nuclear cells (PBMC). Individual blood and faecal
samples were collected to examine humoral immune re-
sponse and faecal shedding of MAP before the first
inoculation and in regular intervals after inoculation.
The amount of blood that could be collected from very
young goat kids was limited because of animal welfare
reasons, therefore, testing of the cellular immune re-
sponse started only 5–6 weeks post inoculation (wpi)
and continued until necropsy (Figure 7).
As scheduled, goats were euthanized and necropsied
about 12 months after the last inoculation. A few
animals died or had to be necropsied earlier for animal
welfare reasons (Table 6). Gross and histologic lesions,
amount of MAP in lesions detected by immunohisto-
chemistry, and bacterial organ burden were recorded.
Emphasis was laid on elaboration of detailed qualitative
and semi-quantitative scoring systems for bacteriological
and pathomorphological parameters.
Preparation of bacteria used for inoculation
A low passage MAP field isolate from the ICV-LN of a
cow (JII-1961) was propagated in Middlebrook 7H9
broth (MB, Becton Dickinson, Heidelberg, Germany)
containing glycerine (Merck, Darmstadt, Germany),
OADC (Becton Dickinson, Heidelberg, Germany) and
Mycobactin J (Allied Monitor, Fayette, MO, US) at 37 ±
2 °C. No antibiotics were added. After centrifugation,of inoculation and time point of necropsy
41-43 dpn
V2 K2 V3 V4
7 6 6 7
20 - 10 20
0.57x107 - 1.62 ± 0.73x107
4.16x108 - 1.62x108 3.24x108
4.16x109 - 1.62x109 3.24x109
49b) 46 47 48c)
imal was necropsied at 39 wpi; b)one animal each died at 37 and 39 wpi, one
pi.
Figure 7 Schematic representation of the time course of the experiment. Challenge time and dose, animal number: V1 – 3–5 dpn, 10 mg
bwm, n = 7; V2 – 3–5 dpn, 20 mg bwm, n = 7; V3 – 42 dpn, 10 mg bwm, n = 6; V4 – 42 dpn, 20 mg bwm, n = 7. Controls: K1 – 3–5 dpn, n = 6;
K2 – 42 dpn, n = 6.
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ferent parallel culture batches originating from the same
pre-culture were re-suspended in small volumes of cul-
ture medium, pooled, and dispensed to form the bacter-
ial inoculum stocks. After centrifugation of the stocks,
the bacterial wet mass (bwm) of each pellet was deter-
mined. The stocks were stored at 5 ± 3 °C for a max-
imum of 9 weeks. One stock was used per inoculation
day. Two to three days before inoculation the pellet was
re-suspended to a concentration of 1 mg bwm/mL using
PBS. This batch suspension was incubated at 37 ± 2 °C
until the day of inoculation. Then, either 10 mL (groups
V1 and V3) or 20 mL (groups V2 and V4) of the suspen-
sion were dispensed into separate tubes to form the in-
oculum for each individual animal. Bacterial counts of
the respective batch suspension were determined on
plates of Middlebrook 7H10 agar (Becton Dickinson,
Heidelberg, Germany) containing OADC, Mycobactin J
and Amphotericin B (AppliChem, Darmstadt, Germany).
Serial dilutions from 10−1 to 10−9 were performed in
MB and 100 μl of each dilution was plated on the agar
plates. Plates were incubated at 37 °C for six weeks.
Colony numbers were counted from the three highest
dilutions showing visible colonies. Bacterial counts
were expressed as the mean of the colony numbers cor-
rected for the dilution. The bacterial inoculum
amounted to 1.62 – 4.16 × 108 cfu/dose (Table 6). For
further characterization of the batch suspensions, acid-
fast bacilli (AFB) were confirmed by Ziehl-Neelsen
staining, MAP was confirmed by IS900 PCR using
primers according to Englund et al. [41]. Freedom from
contaminating bacteria was proved by inoculation on
blood agar plates.
Oral administration
Each individual MAP dose was suspended in 50 mL of
pre-warmed milk replacer in a baby bottle. The goats
were bottle-fed with the inoculum prior to regular
morning feeding. Control animals received the same
amount of pure milk replacer.Faecal culture
Three gram of faeces were placed into 30 mL of 0.75%
HPC. The solution was mixed vigorously, allowed to set-
tle for five min and the supernatant transferred to a
fresh vial. The samples were agitated on a shaker for
30 min and then incubated in upright position for
48 hours at room temperature (RT) in the dark. The su-
pernatants were discarded and 200 μL of the pellet were
transferred on each of four slopes of Herrold’s Egg Yolk
Medium with Mycobactin J and Amphotericin, Nalidixic
acid and Vancomycin (ANV, HEYM, Becton Dickinson,
Heidelberg, Germany). The cultures were incubated up
to 6 months at 37 ± 2 °C and checked every 2 weeks for
contamination and occurrence of visible colonies. As
soon as colonies became visible, colony counts were esti-
mated semi-quantitatively by a colony score (CS) from 1
to 5, with 1 = 0 – 10; 2 = 11 – 20; 3 = 21 – 50; 4 = 51 –
100 individual colonies per slope; 5 = bacterial lawn, and
the week of appearance (WA) was recorded. To correct
for the time until colonies became visible, a growth
index (GI) allowing a numerical estimation of the MAP
concentration in the samples was calculated by the for-
mula: GI = CS × 100/WA. The mean GI of the four cor-
responding slopes was determined.
Serum preparation and antibody detection
Blood without anti-coagulants was kept for 2–3 hours at
RT, centrifuged at 2000 × g for 20 min, the serum recov-
ered, aliquoted and stored at −20 °C until use. MAP spe-
cific antibodies were detected with the ID Screen
Paratuberculosis Indirect ELISA (ID Vet, Montpellier,
France) according to the instructions of the manufac-
turer. The antibody response is demonstrated by the
sample-to-positive ratio (S/P%) as recommended by the
manufacturer.
Preparation of PBMC
Twenty mL blood containing 75 units per mL sodium-
heparin (SIGMA Taufkirchen, Germany) was layered over
20 mL lymphocyte separation medium (PAA, Pasching,
Austria) and centrifuged at 1500 × g for 30 min at RT.
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Hank’s buffer without calcium and magnesium, re-
suspended in RPMI 1640 medium with glutamine, 10%
foetal calf serum (FCS), 10 mM HEPES and 1% Penicillin/
Streptomycin (all Biochrom, Berlin, Germany) and ad-
justed to 2 x 106 PBMC per mL.
Stimulation assay
PBMC were transferred to 96-well round bottom culture
plates (NUNC, Roskilde, Denmark) to a final cell num-
ber of 2 x 105 PBMC per well. Cells were stimulated in
triplicate with Concanavalin A (Con A, 20 μg/mL,
SIGMA, Taufkirchen, Germany) or Johnin purified pro-
tein derivative (jPPD, 4 μg/mL, kindly provided by D.
Bakker, CVI-WUR, Lelystad, The Netherlands) at 37 ±
2 °C, 5% CO2. Non-stimulated cells served as controls.
Cell supernatants were collected after 24 hours of stimu-
lation for measurement of IFN-γ and after 64 hours for
IL-10.
IFN-γ ELISA
IFN-γ was measured with an in-house capture ELISA
using monoclonal antibodies against bovine IFN-γ (cap-
ture antibody: clone CC330, AbD Serotec, Kidlington,
UK; detection antibody: clone CC302-Biotin, AbD Sero-
tec), HRP-labelled biotin as conjugate (AbD Serotec)
and 3,3′,5,5′-tetramethylbenzidine (TMB) as substrate
(SIGMA, Taufkirchen, Germany). IFN-γ concentration
was determined relative to a dilution series of recombin-
ant bovine IFN-γ (AbD Serotec) from 9.167-0.013 ng/
mL.
IL-10 ELISA
IL-10 was measured with an in-house capture ELISA
using monoclonal antibodies against bovine IL-10 (cap-
ture antibody: clone CC318, AbD Serotec; detection
antibody: clone CC320-Biotin, AbD Serotec), HRP-
labelled biotin and TMB as described for the IFN-γ
ELISA. IL-10 concentration was determined relative to a
dilution series of recombinant bovine IL-10 (kindly pro-
vided by G. Entrican and S. Wattegedera, Moredun Re-
search Institute, Penicuik, Scotland, UK) from 30–0.041
U/mL.
The validity of both, the IFN-γ and the IL-10 ELISA
for caprine samples was determined in preceding stimu-
lation experiments using PBMC of healthy adult goats
(data not shown).
Necropsy and collection of tissue samples
Goats inoculated with MAP were necropsied between 47
and 49 wpi and controls 46 and 48 wpi. Special sampling
was done to obtain intestinal samples of high quality. At
necropsy, the sites of intestine to be collected for hist-
ology were selected while the animals were under deepanesthesia. For this, they were sedated with Xylazin at a
dose of 0.25 mg/kg body weight (BW) IM (Rompun® 2%,
Bayer, Leverkusen, Germany) and anesthetized with
Ketamin hydrochloride at 2.5 mg/kg BW IV (Ketamin
10%, Intervet, Unterschleißheim, Germany) and Diaze-
pam at 0.5 mg/kg BW IV (Faustan®, AWD, Radebeul,
Germany) [42]. The intestine was exposed, segments of
about 5 cm were ligated and filled with 4% neutral buff-
ered formalin (NBF) in the duodenum, four sites of je-
junum (3 m apart), one jejunal Peyer’s patch (JPP) from
the proximal and from the distal jejunum and three sites
(terminal ileum, 50 cm and 150 cm proximal to the ileo-
caecal valve (ICV)) of ileal Peyer’s patch (IPP). Then,
goats were euthanized with 20 mL of pentobarbital IV
(Release®, WDT, Garbsen, Germany), the intestine re-
moved in toto, detached from the mesentery and spread
full length on a table. In addition to the sites mentioned
above, samples were collected from caecum, organized
lymphoid tissue in the colon next to the ileocaecal valve
(ICVPP), at the end of the proximal colon (PCPP) and
in the rectum, central flexure of the colon and descend-
ing colon. JPP, IPP, ICVPP and PCPP are referred to as
organized lymphoid tissue in the intestinal wall
(oGALT). Samples for histology were opened, pinned flat
on styrofoam and fixed in NBF. Samples were also col-
lected at the respective sites for bacterial organ culture.
The remaining intestine was opened, ingesta and mu-
cosa examined and macroscopic lesions documented.
All intestinal lymph nodes were examined and samples
collected from proximal, mid (only bacterial organ cul-
ture) and distal mesenteric lymph nodes (M-LN), ileoco-
lic lymph nodes (ICV-LN) and colonic lymph nodes
(Co-LN, only histology). Then a complete necropsy was
performed and representative tissue samples were col-
lected from tonsils, retropharyngeal LN, spleen, kidney,
liver, hepatic LN for cultural isolation and histology, dia-
phragm, gluteal muscle, and superficial cervical LN (only
for cultural isolation), and from thymus, lung, heart,
aorta, pancreas, adrenal, rumen, abomasum, bone mar-
row, and superficial inguinal LN (only for histology).
Histology and immunohistochemistry (IHC)
Tissue samples were embedded in paraffin and lesions ex-
amined in hematoxylin and eosin (HE)-stained paraffin
sections. Severity of lesions was graded from + to +++,
with + (mild), ++ (moderate) and +++ (severe), distribu-
tion of lesions as focal (f) – up to 3 distinct granulomatous
infiltrates per section; multifocal (mf) – more than 3 dis-
tinct granulomatous infiltrates per section and diffuse
(d) – infiltrates throughout the section. In the intestinal
lymph nodes, granulomatous infiltrates and distinct granu-
lomas with central necrosis and calcification were seen. In
oGALT the following types of lesions were distinguished:
A – small foci of epitheloid cells and multinucleated
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extensive granulomatous infiltrates with many lympho-
cytes; C – small foci of granulomatous infiltrate embedded
in numerous lymphocytes and plasma cells and atrophy of
the organized lymphoid tissue; D – multifocal to diffuse
granulomatous infiltrates with numerous epitheloid cells.
Paraffin sections of all intestinal sites, intestinal lymph
nodes, liver, tonsil, hepatic LN, superficial inguinal LN
and tissues with granulomatous lesions were examined
for MAP by the indirect immunoperoxidase method.
Polyclonal rabbit anti-MAP serum (Dako, Glostrup,
Denmark) was used as primary antibody and peroxidase-
conjugated goat anti-rabbit IgG as secondary antibody
(Dianova, Hamburg, Germany). Sections were pretreated
with trypsin (0.1%, 37 °C, 20 min) for antigen retrieval.
3-amino-9-ethyl carbazole (AEC) was used as chromo-
gen. Sections were counter stained with hematoxylin. As
positive control, a slide from an experimentally inocu-
lated goat in which mycobacteria had been detected by
Ziehl-Neelsen staining and from which MAP had been
isolated by culture was included. As negative control, a
consecutive section of the positive control was incubated
with a polyclonal antiserum directed against non-related
bacteria (Brachyspira hyodysenteriae) instead of the
polyclonal rabbit anti-MAP serum. For each section
which had areas of necrosis, a consecutive section was
incubated with the antiserum against non-related bac-
teria as negative control. The number of mycobacteria
per section was graded using a scoring system adapted
from previous studies as none (less than two labeled
bacteria per section), paucibacillary (up to 50% of mac-
rophages contain MAP, on average 1–10 MAP per macro-
phage, few areas in necrotic centers of granulomas) and
multibacillary (most macrophages contain MAP, on aver-
age >10 MAP per macrophage or uncountable, extensive
areas in necrotic centers of granulomas) [43].
Macroscopic lesions, histological findings and immu-
nohistochemical detection of MAP were summarized as
lesion categories for the intestinal lymph nodes, oGALT,
small intestine and as overall lesions for the individualTable 7 Assignment of lesion categories for mesenteric and il
Lesion category mesenteric and ileocecal LNN oGALT






lesions in 1–2 out of the
3 LNN examined,
paucibacillary
lesions in up to
3 sites of oGALT,
f/mf, paucibacillary
III predominantly extensive lesions,
lesions in all 3 LN, pauci-/
multibacillary
lesions in >3 sites of
oGALT, mf, pauci-/
multibacillary
LNN lymph nodes, oGALT gut-associated lymphoid tissue, f focal, mf multifocal.animal to be able to correlate the morphological findings
with cultural isolation of MAP from organs, faecal shed-
ding and immune reactions. The different sites were dis-
criminated, because severity of lesions varied within
individual goats. The criteria are listed in Table 7.
Tissue culture
Fat and connecting tissue was removed from lymph nodes
and other tissue. Intestine was opened and ingesta
removed. One gram of sample was cut from different loca-
tions, minced with scissors and transferred into a plastic
bag containing 7 mL 0.9% HPC. The samples were ho-
mogenized in a stomacher for 6 min, transferred to a
50 mL tube and agitated on a shaker at 200 rpm for
10 min at RT. Afterwards they were incubated in upright
position for 24 hours at RT in the dark. After centrifuga-
tion at 1880 × g for 20 min at RT, supernatants were dis-
carded and the pellet re-suspended with 1 mL of sterile
phosphate buffered saline (pH 7.2). 200 μL of the pellet
were transferred on each of four slopes of HEYM (Becton
Dickinson, Heidelberg, Germany). The cultures were fur-
ther treated and GI was calculated as described above.
The bacterial organ burden (BOB) was calculated for
the samples from intestine, oGALT and intestinal lymph
nodes separately and in summary by dividing the sum of
the GI’s of the respective tissues by the number of tis-
sues involved. BOB categories were designated as fol-
lows: category I – no growth, category II - BOB ≤ 15,
category III - BOB > 15.
Statistics
Response intensities of inoculation groups were analysed
with the Mann–Whitney U-test, frequencies of categor-
ies of parameters were compared using Pearson’s χ2-test.
The level of significance for all statistical methods ap-
plied was P ≤ 0.05. Results were displayed as ‘Box and
Whisker’ plots. Outlier values are 1.5-3 times of the
length of a box away from the median and extreme
values are further away than three times of the length of
the box.eocecal LNN, oGALT and small intestine and in summary
small intestine summary
pic, no lesions (macroscopic,
histological), no MAP
all 3 sites (LNN, oGALT and
small intestine) are category I
lesions in up to 2 sites of
small intestine, f/mf,
paucibacillary
at least 2 of the 3 sites (LNN,
oGALT, small intestine) are
category II or 1 site is category II,
2 are category I or 1 site each is
category I, category II and category III
lesions in >2 sites of
intestine, mf, pauci-/
multibacillary
at least 2 of the 3 sites (LNN,
oGALT, small intestine) are
category III or 1 site is category III
and the others are category I
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